(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Whitehawk Therapeutics's earnings in 2025 is $27,614,000.On average, 2 Wall Street analysts forecast WHWK's earnings for 2025 to be -$48,758,118, with the lowest WHWK earnings forecast at -$62,655,360, and the highest WHWK earnings forecast at -$34,860,877. On average, 2 Wall Street analysts forecast WHWK's earnings for 2026 to be -$88,801,017, with the lowest WHWK earnings forecast at -$95,160,772, and the highest WHWK earnings forecast at -$82,441,263.
In 2027, WHWK is forecast to generate -$101,284,980 in earnings, with the lowest earnings forecast at -$101,284,980 and the highest earnings forecast at -$101,284,980.